Literature DB >> 22878065

Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress.

Vivek K Gupta1, Yuyi You, Alexander Klistorner, Stuart L Graham.   

Abstract

Tropomyosin-receptor-kinase B (TrkB receptor) activation plays an important role in the survival of retinal ganglion cells (RGCs). This study reports a novel finding that, SH2 domain-containing phosphatase-2 (Shp-2) binds to the TrkB receptor in RGCs and negatively regulates its activity under glaucomatous stress. This enhanced binding of TrkB and Shp2 is mediated through caveolin. Caveolin 1 and 3 undergo hyper-phosphorylation in RGCs under stress and bind to the Shp2 phosphatase. Shp2 undergoes activation under glaucomatous stress conditions in RGCs in vivo with a concurrent loss of TrkB activity. Inhibiting the Shp2 phosphatase restored TrkB activity in cells exposed to excitotoxic and oxidative stress. Collectively, these findings implicate a molecular basis of Shp2 mediated TrkB deactivation leading to RGC degeneration observed in glaucoma.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878065     DOI: 10.1016/j.bbadis.2012.07.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.

Authors:  Wei Wang; Ann Chan; Yu Qin; Jacky M K Kwong; Joseph Caprioli; Ralph Levinson; Ling Chen; Lynn K Gordon
Journal:  Exp Eye Res       Date:  2015-08-13       Impact factor: 3.467

2.  Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress.

Authors:  Vivek K Gupta; Yuyi You; Jonathan C Li; Alexander Klistorner; Stuart L Graham
Journal:  J Mol Neurosci       Date:  2012-10-07       Impact factor: 3.444

3.  Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Hao Cheng; Yiming Pan; Yongzhong Yao; Zhanghua Zhu; Jun Chen; Xitai Sun; Yudong Qiu; Yitao Ding
Journal:  Exp Ther Med       Date:  2017-08-25       Impact factor: 2.447

4.  TrkB Receptor Agonist 7,8 Dihydroxyflavone is Protective Against the Inner Retinal Deficits Induced by Experimental Glaucoma.

Authors:  Vivek Gupta; Nitin Chitranshi; Veer Gupta; Yuyi You; Rashi Rajput; Joao A Paulo; Mehdi Mirzaei; Maarten van den Buuse; Stuart L Graham
Journal:  Neuroscience       Date:  2022-02-23       Impact factor: 3.708

Review 5.  One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.

Authors:  Vivek Gupta; Veer B Gupta; Nitin Chitranshi; Sumudu Gangoda; Roshana Vander Wall; Mojdeh Abbasi; Mojtaba Golzan; Yogita Dheer; Tejal Shah; Alberto Avolio; Roger Chung; Ralph Martins; Stuart Graham
Journal:  Cell Mol Life Sci       Date:  2016-06-22       Impact factor: 9.261

6.  Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection.

Authors:  Nitin Chitranshi; Yogita Dheer; Mehdi Mirzaei; Yunqi Wu; Ghasem H Salekdeh; Mojdeh Abbasi; Veer Gupta; Roshana Vander Wall; Yuyi You; Stuart L Graham; Vivek Gupta
Journal:  Mol Ther       Date:  2018-10-04       Impact factor: 11.454

7.  Role of BDNF/TrkB pathway in the visual system: Therapeutic implications for glaucoma.

Authors:  B A Mysona; J Zhao; K E Bollinger
Journal:  Expert Rev Ophthalmol       Date:  2016-11-23

8.  SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes.

Authors:  Ara Jo; Hyunju Park; Sung-Hee Lee; So-Hee Ahn; Hee Ja Kim; Eun-Mi Park; Youn-Hee Choi
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

9.  Anterograde degeneration along the visual pathway after optic nerve injury.

Authors:  Yuyi You; Vivek K Gupta; Stuart L Graham; Alexander Klistorner
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 10.  TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders.

Authors:  Vivek K Gupta; Yuyi You; Veer Bala Gupta; Alexander Klistorner; Stuart L Graham
Journal:  Int J Mol Sci       Date:  2013-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.